When people recover from viral diseases, they make antibodies that can then be transferred to other affected individuals.
One potential treatment for COVID-19, known as convalescent plasma, may be derived from patients who have already recovered from the disease, and the US Food and Drug Administration (FDA) said Tuesday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results